Ertugliflozin – A newly emerging SGLT2 inhibitor for patients with type 2 diabetes.
27 August 2018 (13:25 - 13:35)
Organised by:
About the speaker
Memphis (United States of America)
6 More presentations in this session
Doctor A. Gitt (Ludwigshafen, DE)
Professor D. McGuire (Dallas, US)
Doctor S. Dagogo-Jack (Memphis, US)
Doctor A. Gitt (Ludwigshafen, DE)
Professor L. Leiter (Toronto, CA)
Doctor A. Gitt (Ludwigshafen, DE)
Professor L. Leiter (Toronto, CA)
Professor D. McGuire (Dallas, US)
Doctor S. Dagogo-Jack (Memphis, US)
Access the full session
The Event
ESC Congress 2018
27 August 2018
13:25 CET
